|
Volumn 34, Issue 5, 1998, Pages 404-410
|
Preselected biopsy for normal-appearing mucose of superficial bladder carcinoma
a a a a a a |
Author keywords
Adjuvant treatment; Preselected mucosal biopsy; Prognostic factors; Superficial bladder carcinoma
|
Indexed keywords
BCG VACCINE;
BLEOMYCIN;
DOXORUBICIN;
EPIRUBICIN;
MITOMYCIN C;
PIRARUBICIN;
TEGAFUR;
UFT;
URACIL;
ADULT;
AGED;
ARTICLE;
BLADDER BIOPSY;
BLADDER CARCINOMA;
BLADDER MUCOSA;
CANCER ADJUVANT THERAPY;
CANCER RECURRENCE;
CARCINOMA IN SITU;
CYSTECTOMY;
FEMALE;
HUMAN;
HUMAN TISSUE;
INTRAVESICAL DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
MULTIVARIATE ANALYSIS;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
SUPERFICIAL CANCER;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOPSY, NEEDLE;
CARCINOMA;
CARCINOMA, TRANSITIONAL CELL;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
CYSTECTOMY;
CYSTOSCOPY;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MUCOUS MEMBRANE;
MULTIVARIATE ANALYSIS;
PROPORTIONAL HAZARDS MODELS;
SENSITIVITY AND SPECIFICITY;
URINARY BLADDER NEOPLASMS;
|
EID: 0031794623
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000019774 Document Type: Article |
Times cited : (13)
|
References (10)
|